Management of Diabetes With Metformin In Patients With Chronic Heart Failure
Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
The Ahmanson-UCLA Cardiomyopathy Center is conducting a clinical research study that will
assess the use of the medication metformin to improve quality of life, exercise capacity, and
improved outcomes with patients that have both heart failure and diabetes.
If you participate in this study, you will receive the drug metformin for approximately 3
months. During the study you will undergo comprehensive testing which includes blood draws,
an echocardiogram, and an magnetic resonance imaging (MRI)(if you do not have a pacemaker or
defibrillator). You will also fill out a questionnaire and keep a blood glucose log.
You must be 18 years old to participate. The study drugs, study follow-up visits, and
laboratory tests will be provided free of charge. Participants will be reimbursed up to $200
for their time and travel expenses.